Chroni, Angeliki

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsParaoxonase enzyme and polymorphisms

Cited by 535

Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer

Zannis, V. I., Chroni, A., Kypreos, K. E., Kan, H.-Y., Cesar, T. B., Zanni, E. E., & Kardassis, D. (2004) · Current Opinion in Lipidology

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 74

An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42

Dafnis, I., Stratikos, E., Tzinia, A., Tsilibary, E. C., Zannis, V. I., & Chroni, A. (2010) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 41

The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific

Dafnis, I., Argyri, L., Sagnou, M., Tzinia, A., Tsilibary, E. C., Stratikos, E., & Chroni, A. (2016) · Scientific Reports

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 38

Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy

Georgiadou, D., Stamatakis, K., Efthimiadou, E. K., Kordas, G., Gantz, D., Chroni, A., & Stratikos, E. (2013) · Journal of Lipid Research

Protein Structure and DynamicsLipid Membrane Structure and Behavior

Cited by 37

LCAT can Rescue the Abnormal Phenotype Produced by the Natural ApoA-I Mutations (Leu141Arg)Pisa and (Leu159Arg)FIN

Koukos, G., Chroni, A., Duka, A., Kardassis, D., & Zannis, V. I. (2007) · Biochemistry

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 33

An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines

Dafnis, I., Tzinia, A. K., Tsilibary, E. C., Zannis, V. I., & Chroni, A. (2012) · Neuroscience

Alzheimer's disease research and treatmentsProtease and Inhibitor Mechanisms

Cited by 32

Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4

Argyri, L., Dafnis, I., Theodossiou, T. A., Gantz, D., Stratikos, E., & Chroni, A. (2014) · Journal of Biological Chemistry

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 30

Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Chroni, A., Pyrpassopoulos, S., Thanassoulas, A., Nounesis, G., Zannis, V. I., & Stratikos, E. (2008) · Biochemistry

Protein Structure and DynamicsAlzheimer's disease research and treatments

Cited by 26

Biophysical Analysis of Apolipoprotein E3 Variants Linked with Development of Type III Hyperlipoproteinemia

Georgiadou, D., Chroni, A., Vezeridis, A., Zannis, V. I., & Stratikos, E. (2011) · PLoS ONE

Protein Structure and DynamicsLipid Membrane Structure and Behavior

Cited by 24

Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy

Katsarou, M., Stratikos, E., & Chroni, A. (2018) · Journal of Lipid Research

Alzheimer's disease research and treatmentsLipoproteins and Cardiovascular Health

Cited by 22

Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1

Ljunggren, S. A., Levels, J. H. M., Hovingh, K., Holleboom, A. G., Vergeer, M., Argyri, L., Gkolfinopoulou, C., Chroni, A., Sierts, J. A., Kastelein, J. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 19

Fatty acid-based lipidomics and membrane remodeling induced by apoE3 and apoE4 in human neuroblastoma cells

Prasinou, P., Dafnis, I., Giacometti, G., Ferreri, C., Chroni, A., & Chatgilialoglu, C. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes

Lipid Membrane Structure and BehaviorFatty Acid Research and Health

Cited by 15

A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy

Stratikos, E., & Chroni, A. (2014) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 5

apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL

Fotakis, P., Vezeridis, A., Dafnis, I., Chroni, A., Kardassis, D., & Zannis, V. I. (2014) · Journal of Lipid Research

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 4

Structural and functional insights into naturally occurring apolipoprotein E variants with protective effects against Alzheimer's disease

Georgiadou, D., & Chroni, A. (2026) · International Journal of Biological Macromolecules

Alzheimer's disease research and treatmentsProtein Structure and Dynamics

Cited by 2